Validation of Prognostic Scoring and Assessment of Clinical Benefit for Patients With Bone Sarcomas Enrolled in Phase I Clinical Trials

Oncotarget - United States
doi 10.18632/oncotarget.10910
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Clinical Benefit of Patients With Advanced Adrenocortical Carcinoma (Acc) Treated in Phase I Clinical Trials: The Royal Marsden Hospital (Rmh) Experience

Endocrine Abstracts
2016English

Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials

Clinical Genitourinary Cancer
OncologyUrology
2014English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Clinical Benefit in Phase-I Trials of Novel Molecularly Targeted Agents: Does Dose Matter?

British Journal of Cancer
Cancer ResearchOncology
2009English

Time to Progression Ratio in Cancer Patients Enrolled in Early Phase Clinical Trials: Time for New Guidelines?

British Journal of Cancer
Cancer ResearchOncology
2018English

P1.01-26 Single-Centre Experience of Clinical Outcomes for Advanced Lung Cancer Patients in Phase I Clinical Trials

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Progression-Free Survival Decreases With Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials

Journal of Cancer
Oncology
2012English

Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2000English

Clinical Trials in Oncology and Defining Benefit

Oncologist
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy